The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
WITHDRAWN:Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer.
 
Sora Kang
No Relationships to Disclose
 
So Heun Lee
No Relationships to Disclose
 
Hee Jin Lee
No Relationships to Disclose
 
Hyehyun Jeong
No Relationships to Disclose
 
Jae Ho Jeong
No Relationships to Disclose
 
Jeong Eun Kim
No Relationships to Disclose
 
Jin-Hee Ahn
No Relationships to Disclose
 
Kyung Hae Jung
Consulting or Advisory Role - AstraZeneca; Bixink; Celgene; Eisai; Everest Medicine; Merck; Novartis; Roche; Takeda
 
Gyungyub Gong
No Relationships to Disclose
 
Hak Hee Kim
No Relationships to Disclose
 
Sae Byul Lee
No Relationships to Disclose
 
Jong Won Lee
No Relationships to Disclose
 
Sung-Bae Kim
Stock and Other Ownership Interests - Genopeaks; Neogene Therapeutics; TC Corp
Honoraria - DAEHWA Pharmaceutical; Kalbe Farma; LegoChem Biosciences
Consulting or Advisory Role - AstraZeneca; BeiGene; DAEHWA Pharmaceutical; Daiichi Sankyo/Astra Zeneca; ISU Abxis; Lilly (Inst); OBI Pharma
Research Funding - Dongkook Pharma (Inst); Genzyme (Inst); Novartis (Inst)